佰仁医疗：胶原蛋白植入剂产品获批注册 是国内首款用于面颊部真皮层注射以改善面颊部平滑度的胶原蛋白产品

Group 1 - The core product, a collagen implant (Collagen Fibrils & Fibers), has received approval from the National Medical Products Administration, marking it as the first collagen product in China for dermal injection to improve cheek smoothness [2] - The product features a stable triple helix structure and self-assembles into an ordered fibrous supramolecular structure, enhancing extracellular matrix metabolism and improving skin texture and elasticity [2] - The innovative technology includes a proprietary ultra-pure extraction process and precise peptide cleavage, ensuring the amino acid sequence aligns with human type I collagen, confirmed by clinical trials to have no immunogenicity differences from natural human collagen [2] Group 2 - The product's core technology is based on years of experience in the collagen field, laying the groundwork for future developments in collagen types II and III, as well as other medical applications [3] - The successful launch of this product represents a milestone for the company's innovative platform in animal-derived implant materials, showcasing the advantages of its platform-based operations [3]